The prognostic utility of the transcription factor SRF in docetaxel-resistant prostate cancer: in-vitro discovery and in-vivo validation.
BMC Cancer
; 17(1): 163, 2017 03 01.
Article
in En
| MEDLINE
| ID: mdl-28249598
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostatic Neoplasms
/
Drug Resistance, Neoplasm
/
Oligonucleotide Array Sequence Analysis
/
Gene Expression Profiling
/
Serum Response Factor
Type of study:
Prognostic_studies
Limits:
Humans
/
Male
Language:
En
Journal:
BMC Cancer
Journal subject:
NEOPLASIAS
Year:
2017
Type:
Article
Affiliation country:
Ireland